Pharma stocks crater as investors brace for billions in heartburn drug litigation charges
Shares of GlaxoSmithKline, Sanofi, and Haleon all sold off sharply this week, shedding tens of billions in market value, amid investor fear over potential U.S. litigation charges focused on popular heartburn drug Zantac. This has been a known issue bubbling … Read more